IPM clocks growth rate of 9.4 per cent in 2018: AIOCD AWACS report
Indian pharmaceutical market,IPM,AIOCD AWACS,MAT,December 2018
Author
Glenmark Pharma in agreement with Yuhan Corporation
To commercialise investigational seasonal allergic Rhinitis Nasal Spray Ryaltris in South Korea
Sun Pharma recalls about 14k cartons of anaesthesia injection from US market
Vecuronium Bromide for injection is used as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to…
Eli Lilly to buy Loxo Oncology for $8 billion
The deal follows Bristol-Myers Squibb Co agreement last week to buy Celgene Corp for $74 billion, and gives Lilly access to Loxo’s…
Lupin recalls over 23,000 bottles of antibiotic drug in US
The drug is manufactured by Novel Laboratories for Baltimore-based Lupin Pharmaceuticals
Pfizer to stop manufacturing operations in two units
Both the plants located in Maharashtra and Tamil Nadu are export-oriented and came under Pfizer's ownership after it acquired…
Lupin gets European Commission nod for myotonia treatment drug
The approval makes NaMuscla (mexiletine) the first treatment to be licensed throughout the EU for the symptomatic treatment of…
EyeC to present print inspection solutions for pharma packaging at Pharmapack 2019
The products will be exhibited at booth C2
Merck loses bid to revive $200 million Gilead verdict at US high court
Merck had urged the Supreme Court to place limits on the doctrine of 'unclean hands' that can prevent plaintiffs from winning…
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal
The two companies said the new arrangement would give Sanofi increased flexibility to advance its early-stage immuno-oncology…